Exactitude_Consultancy_Logo.png
Advanced Process Control Market Projected to Grow from USD 2.44 Billion in 2024 to USD 4.89 Billion by 2029, at a CAGR of 8.14% | Exactitude Consultancy
12. September 2024 08:25 ET | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
axogen logo.jpg
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
03. September 2024 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
axogen logo.jpg
Axogen, Inc. Announces New Leadership Appointments
08. August 2024 07:05 ET | Axogen, Inc.
The Board of Directors appoints Michael Dale as new CEO and Director, effective August 9, 2024Dale replaces Karen Zaderej, who will remain in an advisory role for nine monthsCurrent Member of the...
axogen logo.jpg
Axogen, Inc. Reports Second Quarter 2024 Financial Results
08. August 2024 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
28. Mai 2024 16:30 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
16. Mai 2024 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen, Inc Reports First Quarter 2024 Financial Results
02. Mai 2024 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
Logo.jpg
Advanced Process Control Market To Reach USD 4.9 Billion By 2032 | DataHorizzon Research
03. April 2024 06:50 ET | DataHorizzon Research
Fort Collins, Colorado, April 03, 2024 (GLOBE NEWSWIRE) -- The Advanced Process Control Market size was valued at USD 2.5 Billion in 2023 and is anticipated to grow CAGR at 7.8% to reach USD 4.9...
axogen logo.jpg
Axogen Announces Transition of Finance Team Leadership
06. Dezember 2023 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
axogen logo.jpg
Axogen, Inc. Reports 2023 Third Quarter Financial Results
07. November 2023 07:00 ET | Axogen, Inc.
ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...